CGRP Education & Research Forum
Already a member? Become a member Register
youtubeLinkedIn
News

Atogepant

Atogepant

Atogepant is an oral CGRP receptor antagonist (gepant) in development for the prevention of migraine. Results of a Phase 2b/3 study and the Phase 3 ADVANCE trial will form the basis of regulatory submissions for atogepant in migraine prevention in adults.


Download slideset »


« back to Slides